StockWatch
·
Biotechnology: Pharmaceutical Preparations
Board MeetingJul 22, 2026, 05:08 PM

Supernus Q2 2026 Earnings Call Scheduled for August 4

AI Summary

Supernus Pharmaceuticals, Inc. announced it will report its second quarter 2026 financial and business results after the market closes on Tuesday, August 4, 2026. Following the release, President and CEO Jack Khattar and Senior Vice President and CFO Tim Dec will host a conference call and webcast at 4:30 p.m. ET to discuss the results. A live webcast will be available on the company's Investor Relations website, with a replay accessible for 60 days.

Key Highlights

  • Supernus Pharmaceuticals to report second quarter 2026 financial and business results.
  • Results will be released after market close on Tuesday, August 4, 2026.
  • Conference call and webcast scheduled for August 4, 2026, at 4:30 p.m. ET.
  • Jack Khattar (President & CEO) and Tim Dec (SVP & CFO) will host the call.
  • Live webcast accessible via the company's Investor Relations website.
  • Replay of the webcast will be available for 60 days on the website.